Article Details
Retrieved on: 2021-05-24 16:25:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
At just 1% of the proposed oral dose of hydroxychloroquine to treat COVID-19, intratracheally administered ISPM19 had a longer half-life (around 2.5- ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here